Department of Neurosurgery, Saiseikai Utsunomiya Hospital, 911-1 Takebayashimachi, Utsunomiya, Tochigi, 321-0974, Japan.
Department of Neurosurgery, Keio University School of Medicine, 35 Shinanomachi, Shinjuku-ku, Tokyo, 160-8582, Japan.
Brain Pathol. 2018 Jan;28(1):87-93. doi: 10.1111/bpa.12468. Epub 2017 Feb 9.
A rosette-forming glioneuronal tumor (RGNT) is a rare mixed neuronal-glial tumor characterized by biphasic architecture of glial and neurocytic components. The number of reports of genetic analyses of RGNTs is few. Additionally, the genetic background of the unique biphasic pathological characteristics of such mixed neuronal-glial tumors remains unclear. To clarify the genetic background of RGNTs, we performed separate comprehensive genetic analyses of glial and neurocytic components of five RGNTs, by tissue microdissection. Two missense mutations in FGFR1 in both components of two cases, and one mutation in PIK3CA in both components of one case, were detected. In the latter case with PIK3CA mutation, the additional FGFR1 mutation was detected only in the glial component. Moreover, the loss of chromosome 13q in only the neurocytic component was observed in one other case. Their results suggested that RGNTs, which are tumors harboring two divergent differentiations that arose from a single clone, have a diverse genetic background. Although previous studies have suggested that RGNTs and pilocytic astrocytomas (PAs) represent the same tumor entity, their results confirm that the genetic background of RGNTs is not identical to that of PA.
胶神经元细胞肿瘤(RGNT)是一种罕见的混合性神经元-神经胶质肿瘤,其特征为具有胶质和神经细胞成分的双相结构。关于 RGNT 的基因分析报告数量较少。此外,这种混合性神经元-神经胶质肿瘤独特的双相病理特征的遗传背景尚不清楚。为了阐明 RGNT 的遗传背景,我们通过组织微切割对 5 例 RGNT 的胶质和神经细胞成分分别进行了全面的遗传分析。在两个病例的两个成分中均检测到 FGFR1 的两个错义突变,在一个病例的两个成分中均检测到 PIK3CA 的一个突变。在后一个具有 PIK3CA 突变的病例中,仅在胶质成分中检测到额外的 FGFR1 突变。此外,在另一个病例中,仅在神经细胞成分中观察到 13q 染色体缺失。他们的结果表明,RGNT 是一种起源于单个克隆的具有两种不同分化的肿瘤,具有多样化的遗传背景。尽管之前的研究表明 RGNT 和毛细胞星形细胞瘤(PA)代表同一肿瘤实体,但他们的结果证实 RGNT 的遗传背景与 PA 并不相同。